Visual Performance of Highly Aspherical Lenslet Spectacles in Children (Ancillary to WS10246) (FIN-3102)
Clinical Evaluation of Vision Performance of the FIN C2 Lens
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
San Diego, California, United States, 92131
- Scripps Poway Optometry
-
-
Florida
-
Longwood, Florida, United States, 32779
- Sabal Eye Care
-
-
Illinois
-
Chicago, Illinois, United States, 60616
- Illinois College of Optometry
-
-
Kansas
-
Pittsburg, Kansas, United States, 66762
- Kannarr Eye Care
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- New England College of Optometry
-
-
New York
-
New York, New York, United States, 10036
- SUNY College of Optometry
-
Vestal, New York, United States, 13850
- Sacco Eye Group
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Existing subjects from Essilor R&D Study WS10246 clinical study.
- Ability to comply with study procedures.
- Informed consent of parent/guardian and assent of subject.
Exclusion Criteria:
- Current ocular infection, inflammation, or irritation likely to affect vision.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: HAL spectacle lens
HAL spectacle lens using a innovative spectacle lens to control myopia progression
|
HAL spectacle lens for myopia control
|
|
Placebo Comparator: Single vision spectacle lens
Single vision spectacle lens for myopia and astigmatism correction
|
Single vision spectacle lens for myopia and astigmatism correction
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reading Speed
Time Frame: Between Year 1 and Year 2 of the WS10246 study, representing an average timeframe of 1.5 years into the parent study.
|
Reading speed (mean words per minute) collected using the Wolffsohn Research iPad OptomCentral App
|
Between Year 1 and Year 2 of the WS10246 study, representing an average timeframe of 1.5 years into the parent study.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Binocular distance high contrast visual acuity (VA) through the lens periphery
Time Frame: Between Year 1 and Year 2 of the WS10246 study, representing an average timeframe of 1.5 years into the parent study.
|
Measured to the nearest letter using a standard ETDRS chart at 4 meters.
|
Between Year 1 and Year 2 of the WS10246 study, representing an average timeframe of 1.5 years into the parent study.
|
|
Binocular photopic near contrast sensitivity function (CSF)
Time Frame: Between Year 1 and Year 2 of the WS10246 study, representing an average timeframe of 1.5 years into the parent study.
|
Evaluated at 40 cm using the iPad OptomCentral App across various spatial frequencies to calculate the Area Under the Log Contrast Sensitivity Function (AULCSF).
|
Between Year 1 and Year 2 of the WS10246 study, representing an average timeframe of 1.5 years into the parent study.
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Study Director: Jason Shen, PhD, Essilor International, Affiliation of EssilorLuxottica
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- WS10353
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.